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Abstract
Introduction. Primary acinic cell carcinoma (ACC) is an un-
common malignant neoplasm of the salivary gland (SG), which
usually presents as slow growing tumor. Case report. We re-
ported a 69-year-old woman with tumor in the right parotid
gland with a 5-year progress. Biopsy sections revealed a hybrid
f o r m  o f  A C C  w i t h  a  l o w -  a n d  h i g h - g r a d e  c o m p o n e n t  a n d
prominent lymphoid tissue in tumor stroma. Immunohisto-
chemistry was performed to define the molecular profile of this
unusual ACC, with special interest for stromal influence on to
the proliferative activity of ACC with dedifferentiation. We
detected that the level and the type of stromal lymphoid reac-
tion (particularly CD8+/CD4+ ratio) had a significant influence
on to Ki-67 index in the high-grade component of ACC, as
well as the  involvement of the CXCR4 signaling axis in the
stromal reaction influence. Conclusion. We suggest that tu-
mor stroma may be a source of potential new tumor biomark-
ers which can determine the aggressivity of this tumor.
Key words:
parotid neoplasms; carcinoma, acinar cell; ki-67
antigen; prognosis.
Apstrakt
Uvod. Primarni acinoýelijski karcinom (ACC) je redak mali-
gni tumor pljuvaÿnih žlezda koji obiÿno ima sporu progre-
siju. Prikaz bolesnika. U radu je prikazana bolesnica, stara
69 godina, sa tumorom u desnoj parotidnoj žlezdi. Na pre-
secima tkiva otkrivena je hibridna forma ACC, sa kompo-
nentom niskog i visokog gradusa, i izraženim limfnim tki-
vom u stromi tumora. Tumor je pokazivao 5-godišnju pro-
gresiju. Imunohistohemijska metoda korišýena je kako bi se
definisao molekularni profil ove retke forme ACC, kao i uti-
caj strome na proliferativnu aktivnost ACC sa njegovom
dediferencijacijom. Pokazali smo da nivo i tip stromalne
limfoidne reakcije (pogotovo odnos CD8+/CD4+) ima zna-
ÿajan uticaj na Ki-67 indeks u komponenti visokog gradusa
ACC, kao i uticaj CXCR4 signalnog puta. Zakljuÿak. Tu-
morska stroma može biti izvor potencijalno novih tumor-
skih biomarkera, kada imuni odgovor može uticati na agre-
sivnost ovog tumora.
Kljuÿne reÿi:
parotidne žlezde, neoplazme; karcinom acinusnig
ýelija; antigen, ki-67; prognoza.
Introduction
Although acinic cell carcinomas (ACCs) represent only
2–6% of salivary gland tumors, they are the third most com-
mon epithelial malignancy after mucoepidermoid carcinoma,
thus being about 10% of all malignant salivary gland tu-
mors 
1. Well-differentiated ACCs present as well circum-
scribed encapsulated tumors with a solid or microcystic pat-
tern in which tumor cells are surrounded and intermingled
with prominent lymphoid response. Dedifferentiated ACC
presents itself with areas of low-grade ACC and areas of de-
differentiated high grade ACC, or undifferentiated carcinoma
within the same tumor 
2, 3. Investigation of biological mark-
ers is very important and necessary for predicting prognosis
of salivary malignancies and better understanding the patho-
genesis of salivary cancer. Ki-67 was already proven as use-
ful prognostic markers for survival in a few studies of pa-
tients with ACC and other salivary glands tumors 
4, 5. Tumor
stroma may be a source of potential new tumor biomarkers,
in which the immune response is of major importance. Here
we investigated stromal influence onto the proliferative ac-
tivity of ACC with dedifferentiation and evolution of this pa-
rotid gland tumor.
Case report
A 69-year-old woman presented with a superficial
lobulated swelling in the lower half of the right parotidStrana 1156 VOJNOSANITETSKI PREGLED Volumen 70, Broj 12
Jankoviý Veliÿkoviý Lj, et al. Vojnosanit Pregl 2013; 70(12): 1155–11580.
gland. The tumor had been detected 5 years before with the
diameter of 1 u 1 cm, clinically manifested as slowly en-
larging, asymptomatic, painless tumor mass. Five years later
surgical resection of the lower part of the parotid gland was
performed, as well as extirpation of a lymph node along the
front edge of the sternocleidomastoidal muscle.
Pathological and immunohystochemical findings
In a fragment of the parotid gland (45 u 40 mm), gross
analysis showed a well- circumscribed tan-gray tumor mass
of strong consistency (38 u 30 u 10 mm), and a focus of
bleeding (12 mm). Microscopically, biopsy sections revealed
feature of ACC where tumor cells had basophilic cytoplasm
and acinar differentiation. The tumor showed predominantly
a low-grade component, but in some parts of ACC, a high-
grade component was detected. Abundant lymphoid tissue
with germ cell follicles was present in tumor stroma (Figure
1a). Some parts of a high-grade component showed promi-
nent stromal lymphoid reaction with intratumoral infiltration
of lymphocytes. Regional lymph node showed reactive hy-
perplastic change. The tumor was in pathological stage 2.
Fig. 1 – a) Acinic cell carcinomas (ACC) of the parotid gland
with abundant stromal lymphoid tissue in high grade com-
ponent (HE staining, u 40); b) Immunoreactivity in high
grade ACC with stromal reaction and low Ki-67 index
(u 40); c) prominent Ki-67 index in part of tumor with
scanty stromal reaction (u 40); d) with infiltration of tumor
with CD8
+ cell (u 40); e) and CD4
+ cells (u 40); f) CXCR4
positivity in both tumor cells and lymphocytes (u 40).
Broad spectrum of monoclonal antibodies was applied to
define the molecular profile of low and high-grade compo-
nents of ACC, and surrounding lymphoid stromal influence on
to Ki-67 index. Immunohistochemical analysis was performed
on the following 3 different tumor regions: low-grade, high-
grade near prominent stromal reaction, and high-grade with a
low stromal reaction. The tumor was analyzed using the
mouse monoclonal antibody against p53, p21
WAF1/Cip1, HER-2,
Ki-67, Bcl-2, Survivin, Bax, Fas, Caspase-3, CD4, CD8,
CXCR4, GFAP, EMA, S-100, CEA, and CK (AE1/AE3). We
defined indexes of  Ki-67, p53, p21 and Survivin. On the lit-
erature data scoring system was performed to p21 
6; Bcl-2,
Bax, Fas, and Caspase 3 
7, and CXCR4 
8. For testing the HER-
2 (C-erbB2) status we used the HercepTest scoring system de-
vised by DAKO. Characterization of the stromal reaction and
a mononuclear cell infiltrate was determined based on the hot
spot technique, which means that, in each studied tumor area,
density was measured at the region of the highest tumor-
infiltrating lymphocytes (TILs) density 
9. The TILs were fur-
ther characterized by CD4 and CD8 markers expression and
the percentage of CD4 and CD8 positive TILs was scored as:
score 0, no immunoreactive cells; score +1, positivity in <
10% cells; score +2, positivity in 10–30% cells; and score +3,
positivity in > 30% of cells. Pathology data regarding prolif-
erative index Ki-67, p21, CD4 and CD8 positivity were ana-
lyzed by the analysis of variance (ANOVA), single-factor
analysis and the Ȥ2 test, and p < 0.05 was considered to be sta-
tistically significant.
Mitotic activity increased in the part of tumor with a
high-grade component (Figure 1b, 1c), but it was significantly
higher (p < 0.05) in high-grade AAC with scanty stroma. TILs
showed the specific pattern of immunoreactivity. In high-
grade tumor with strong lymphoid stromal reaction, CD8
+
cells infiltrating the tumor outnumbered the CD4+ cells (Fig-
ure 1d, 1e), and as a result, the CD4
+/CD8
+ ratio was below
0.5 (Figure 1d, 1e). In the low grade tumor and normal im-
mune response this ratio is between 0.9 and 1.9. In the same
area both TILs and tumor cells showed an increase in the den-
sity of CXCR4 positive cells (Figure 1f) and a decrease in the
tumor cells mitotic activity (Figure 1b). A similar trend was
seen in the case of stromal CD4
+ and CD8
+ cells.
 Ki-67 index and quantification of CD4
+ cells and CD8
+
cells was shown in Figure 2. The molecular profile of inves-
tigated components in ACC is presented in Table 1.
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Fig. 2 – Lymphoid stromal reaction, Ki-67 and p21
expression in acinic cell carcinoma.
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Table 1
Expression of molecular markers in acinar cell carcinoma
Molecular
markers
Low
grade
High-grade stromal
reaction
High
grade
p53 – – –
p21% – Score 1 Score 2
HER-2 – Score 2 Score 2
Ki-67 Score 1 Score 2 Score 1
Bcl-2 – altered altered
Survivin – – –
Bax normal altered altered
Fas altered altered altered
Caspase-3 altered – –
CD4 Score 1 Score 3 Score 1
CD8 Score 1 Score 3 Score 1
CXCR4 + + –
GFAP – – –
EMA – – –
S-100 + + +
CEA – – –
Cytokeratin + + +
Discussion
Prognosis of salivary tumors depends mostly on the mi-
croscopic grade and the tumor type, as well as the stage of
the disease and localization 
1–3. Investigation of proliferative
activity in ACCs and other malignant salivary gland tumors,
evaluating MIB-1 or Ki-67 index, shows that this is highly
effective tool in patient follow-up and prognosis. Patients
with MIB-1-negative ACCs had significantly better survival
than patients with MIB-1-positive tumors. This is an inde-
pendent prognostic factor for survival in patients with
ACCs 
4.
Furthermore, TILs showed the specific pattern of im-
munoreactivity regarding the tumor grade as well as the
stroma/tumor ratio. In high-grade tumor with strong lym-
phoid stromal reaction, CD8
+ cells infiltrating the tumor
were a dominant component of immune infiltrate. CD4
+ also
revealed strong expression, although CD8
+ cytotoxic lym-
phocytes highly outnumbered CD4
+ TILs. This would sug-
gest a later phase of the T-cell activation process 
10–12 and
may be a result of a relatively long period of tumor evolu-
tion.
In view of clinical and pathological data, it is specu-
lated that the tumor foci lacking lymphoid stroma possibly
represented a clone of high-grade malignancy arising within
low-grade acinic cell carcinoma with lymphoid stroma. Sev-
eral studies on various carcinomas have shown that a high
CD8
+/CD4
+ T cell ratio is associated with favorable progno-
sis and vice versa 
11, 13, 14. The same area showed an increase
in the density of CXCR4 positive cells in both TILs and tu-
mor cells shown, which also correlated with low prolifera-
tion index. CXCR-4 is an alpha-chemokine receptor specific
for stromal-derived-factor-1 (SDF-1 also called CXCL12), a
molecule endowed with a potent chemotactic activity for
lymphocytes. The CXCR4 signaling pathway is a key regu-
lator of many essential biological processes, such as cell mo-
tility, differentiation switch, apoptosis and lymphocyte
homing 
15, 16. However, data regarding the role of CXCR4 is
sometimes dubious. Until recently, SDF-1 and CXCR4 were
believed to be a relatively “monogamous” ligand-receptor
pair correlated to other chemokine receptors Recent evidence
demonstrates ubiquitin (a well-known anti-inflammatory
immune modulator and endogenous opponent of proinflam-
matory damage) may also be a natural ligand of
CXCR4 
17, 18. There is still no data on the role of this signal-
ing axis in the ACC pathogenesis.
It is well-known that salivary gland cancer may resist
programmed cell death with altered expression of both pro-
apoptotic and antiapoptotic proteins 
4, 5, 19, but this process
can be regulated by expression of HER-1 and p21 20. So, a
weak bcl-2 expression in SG tumors is associated with a high
frequency of apoptosis, but strong Bax expression has no in-
fluence 
19. Some authors suggest that HER2/neu overexpres-
sion in cancer cells, in addition to stimulating tumor cell
proliferation, acts as an antiapoptotic cell survival factor 
20.
On the other hand, cancer cells lacking p21 are more sensi-
tive to apoptosis, by arresting cell cycle progression or p21
could interact with and inhibit proapoptotic molecules, such
as procaspase-3, caspase-8, and apoptosis signal-regulating
kinase 1 
21.
This article describes a very unusual hybrid form of
ACC with slow progression. In this case, a high-grade com-
ponent of ACC showed deregulation of cell cycle, with high
expression of HER-2, p21, and Bcl-2. Proapoptotic markers
were effective in low grade ACC, but with dedifferentiation
of ACC, tumor cells expressed Bax and Fas, however with-
out Caspase-3 activity. Stromal lymphoid tissue had a sig-
nificant influence on to Ki-67 index in a high-grade compo-
nent of ACC, as well as involvement of the CXCR4 signal-
ing axis in the stromal reaction influence.
Conclusion
Stromal lymphoid reaction (particularly CD8
+/CD4
+ ra-
tio) has a significant influence onto Ki-67 index in high-
grade ACC of the parotid gland, which can determine the
aggressivity of this tumor, and therefore may be used as a
novel prognostic biomarker.
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